This week's topics include GLP1s and AUD, impact of CVD risk calculation, meeting lipid lowering targets, and no luck with a vaccine for gonorrhea.
Program notes:
0:38 New guidelines for CVD risk
1:40 21% were reclassified
2:40 More contemporary populations and better data
3:30 Existing meningitis vaccine for gonorrhea
4:30 Incidence in both groups the same
5:30 Randomized trial important
6:18 Prevalence of elevated LDL
7:18 High risk 83% of individuals
8:18 Should be a primary focus
8:30 Taking a GLP1 agonist and AUD
9:30 Did result in fewer hospitalizations for AUD when used
10:30 Relative risk reduction
11:30 Pretty low bar
12:41 End